
AquaBounty Technologies, Inc. (Nasdaq: AQB) filed a Current Report on Form 8-K on November 2, 2026 under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits). The filing marks an important near-term liquidity and restructuring step as management executes on working-capital preservation and asset evaluation.

At a market capitalization of $5.56 million on Nasdaq, AquaBounty trades at a steep discount to historical capital invested in its land-based recirculating aquaculture systems (RAS) and genetically engineered salmon technology. Small-cap agricultural biotech and specialty bio-production issuers have increasingly focused on balance-sheet deleveraging, non-core facility sales, and strategic alternatives to unlock residual equity value.
| Ticker | Company | Exchange | Market Cap | Primary Catalyst & Sector Focus |
|---|---|---|---|---|
| AQB (Subject) | AquaBounty Technologies, Inc. | Nasdaq | $5.56M | Form 8-K (2026-11-02) · Precision Bio-AgTech & Land-Based Aquaculture Biotech |
| $TLRY | Tilray Brands, Inc. | Nasdaq | $1.15B | Agricultural consumer products, wellness & bio-cultivation |
| $CWBHF | Charlotte's Web Holdings, Inc. | OTCQX | $24.5M | Botanical genetics & agricultural wellness extraction |
| $SGMO | Sangamo Therapeutics, Inc. | Nasdaq | $115M | Genomic engineering & strategic balance-sheet restructuring |
| Form | Filing Date | Disclosure Scope | EDGAR Source |
|---|---|---|---|
| 8-K | 2026-11-02 | SEC Form 8-K (Items: 1.01,2.03,9.01) | View EDGAR Filing → |
| 8-K | 2026-10-23 | SEC Form 8-K (Items: 8.01) | View EDGAR Filing → |
| S-3 | 2026-10-13 | SEC Form S-3 | View EDGAR Filing → |
| 8-K | 2026-10-08 | SEC Form 8-K (Items: 1.01,3.02,9.01) | View EDGAR Filing → |
| 8-K | 2026-08-06 | SEC Form 8-K (Items: 7.01,9.01) | View EDGAR Filing → |
Special-situations traders and microcap turnaround desks in the PubCo Insight vault are watching: (1) specific terms and maturity extensions under the November 2 Form 8-K agreement, (2) Ohio and Prince Edward Island asset monetization milestones, and (3) net working capital runway.
Each week: the micro and small-caps now showing dilution or paid-promotion signals, with the SEC filing behind every flag. No recommendations, no price targets.